Works by Haura, Eric


Results: 79
    1
    2
    3
    4
    5
    6

    Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.

    Published in:
    OncoTargets & Therapy, 2017, v. 10, p. 4239, doi. 10.2147/OTT.S136992
    By:
    • Creelan, Ben C.;
    • Gabrilovich, Dmitry I.;
    • Gray, Jhanelle E.;
    • Williams, Charles C.;
    • Tanvetyanon, Tawee;
    • Haura, Eric B.;
    • Weber, Jeffrey S.;
    • Gibney, Geoffrey T.;
    • Markowitz, Joseph;
    • Proksch, Joel W.;
    • Reisman, Scott A.;
    • McKee, Mark D.;
    • Chin, Melanie P.;
    • Meyer, Colin J.;
    • Antonia, Scott J.
    Publication type:
    Article
    7
    8

    Gene therapy for lung cancer.

    Published in:
    Molecular Biotechnology, 2003, v. 25, n. 2, p. 139, doi. 10.1385/MB:25:2:139
    By:
    • Haura, Eric;
    • Sotomayor, Eduardo;
    • Antonia, Scott
    Publication type:
    Article
    9

    Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 517, doi. 10.1007/s00262-018-2287-9
    By:
    • Chiappori, Alberto A.;
    • Williams, Charles C.;
    • Gray, Jhanelle E.;
    • Tanvetyanon, Tawee;
    • Haura, Eric B.;
    • Creelan, Ben C.;
    • Thapa, Ram;
    • Chen, Dung-Tsa;
    • Simon, George R.;
    • Bepler, Gerold;
    • Gabrilovich, Dmitry I.;
    • Antonia, Scott J.
    Publication type:
    Article
    10

    A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1853, doi. 10.1007/s00262-018-2236-7
    By:
    • Gray, Jhanelle E.;
    • Chiappori, Alberto;
    • Williams, Charlie C.;
    • Tanvetyanon, Tawee;
    • Haura, Eric B.;
    • Creelan, Ben C.;
    • Kim, Jongphil;
    • Boyle, Theresa A.;
    • Pinder-Schenck, Mary;
    • Khalil, Farah;
    • Altiok, Soner;
    • Devane, Rebecca;
    • Noyes, David;
    • Mediavilla-Varela, Melanie;
    • Smilee, Renee;
    • Hopewell, Emily L.;
    • Kelley, Linda;
    • Antonia, Scott J.
    Publication type:
    Article
    11

    Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.

    Published in:
    Carcinogenesis, 2018, v. 39, n. 3, p. 336, doi. 10.1093/carcin/bgx113
    By:
    • Yafang Li;
    • Xiangjun Xiao;
    • Younghun Han;
    • Gorlova, Olga;
    • Qian, David;
    • Leighl, Natasha;
    • Johansen, Jakob S.;
    • Barnett, Matt;
    • Chu Chen;
    • Goodman, Gary;
    • Cox, Angela;
    • Taylor, Fiona;
    • Woll, Penella;
    • Wichmann, H.-Erich;
    • Manz, Judith;
    • Muley, Thomas;
    • Risch, Angela;
    • Rosenberger, Albert;
    • Arnold, Susanne M.;
    • Haura, Eric B.
    Publication type:
    Article
    12

    SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.

    Published in:
    Carcinogenesis, 2014, v. 35, n. 8, p. 1717, doi. 10.1093/carcin/bgu025
    By:
    • Schneeberger, Valentina E.;
    • Luetteke, Noreen;
    • Ren, Yuan;
    • Berns, Hartmut;
    • Chen, Liwei;
    • Foroutan, Parastou;
    • Martinez, Gary V.;
    • Haura, Eric B.;
    • Chen, Jiandong;
    • Coppola, Domenico;
    • Wu, Jie
    Publication type:
    Article
    13
    14

    An immunoproteomic approach to characterize the CAR interactome and signalosome.

    Published in:
    Science Signaling, 2019, v. 12, n. 568, p. N.PAG, doi. 10.1126/scisignal.aap9777
    By:
    • Ramello, Maria C.;
    • Benzaïd, Ismahène;
    • Kuenzi, Brent M.;
    • Lienlaf-Moreno, Maritza;
    • Kandell, Wendy M.;
    • Santiago, Daniel N.;
    • Pabón-Saldaña, Mibel;
    • Darville, Lancia;
    • Fang, Bin;
    • Rix, Uwe;
    • Yoder, Sean;
    • Berglund, Anders;
    • Koomen, John M.;
    • Haura, Eric B.;
    • Abate-Daga, Daniel
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 3, p. 448, doi. 10.1002/cncr.29042
    By:
    • Villaruz, Liza C.;
    • Socinski, Mark A.;
    • Abberbock, Shira;
    • Berry, Lynne D.;
    • Johnson, Bruce E.;
    • Kwiatkowski, David J.;
    • Iafrate, A. John;
    • Varella‐Garcia, Marileila;
    • Franklin, Wilbur A.;
    • Camidge, D. Ross;
    • Sequist, Lecia V.;
    • Haura, Eric B.;
    • Ladanyi, Mark;
    • Kurland, Brenda F.;
    • Kugler, Kelly;
    • Minna, John D.;
    • Bunn, Paul A.;
    • Kris, Mark G.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs.

    Published in:
    JAMA: Journal of the American Medical Association, 2014, v. 311, n. 19, p. 1998, doi. 10.1001/jama.2014.3741
    By:
    • Kris, Mark G.;
    • Johnson, Bruce E.;
    • Berry, Lynne D.;
    • Kwiatkowski, David J.;
    • Iafrate, A. John;
    • Wistuba, Ignacio I.;
    • Varella-Garcia, Marileila;
    • Franklin, Wilbur A.;
    • Aronson, Samuel L.;
    • Pei-Fang Su;
    • Yu Shyr;
    • Camidge, D. Ross;
    • Sequist, Lecia V.;
    • Glisson, Bonnie S.;
    • Khuri, Fadlo R.;
    • Garon, Edward B.;
    • Pao, William;
    • Rudin, Charles;
    • Schiller, Joan;
    • Haura, Eric B.
    Publication type:
    Article
    35
    36
    37

    Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 6, p. 2509, doi. 10.1172/JCI67250
    By:
    • Hopewell, Emily L.;
    • Weipeng Zhao;
    • Fulp, William J.;
    • Bronk, Crystina C.;
    • Lopez, Alexis S.;
    • Massengill, Michael;
    • Antonia, Scott;
    • Celis, Esteban;
    • Haura, Eric B.;
    • Enkemann, Steven A.;
    • Chen, Dung-Tsa;
    • Beg, Amer A.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

    Published in:
    Oncogene, 2002, v. 21, n. 13, p. 2000, doi. 10.1038/sj.onc.1205260
    By:
    • Niu, Guilian;
    • Wright, Kenneth L.;
    • Huang, Mei;
    • Song, Lanxi;
    • Haura, Eric;
    • Turkson, James;
    • Shumin Zhang;
    • Wang, Tianhong;
    • Sinibaldi, Dominic;
    • Coppola, Domenico;
    • Heller, Richard;
    • Ellis, Lee M.;
    • Karras, James;
    • Bromberg, Jacqueline;
    • Pardoll, Drew;
    • Jove, Richard;
    • Hua Yu
    Publication type:
    Article
    48
    49

    Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16212-w
    By:
    • Vander Velde, Robert;
    • Yoon, Nara;
    • Marusyk, Viktoriya;
    • Durmaz, Arda;
    • Dhawan, Andrew;
    • Miroshnychenko, Daria;
    • Lozano-Peral, Diego;
    • Desai, Bina;
    • Balynska, Olena;
    • Poleszhuk, Jan;
    • Kenian, Liu;
    • Teng, Mingxiang;
    • Abazeed, Mohamed;
    • Mian, Omar;
    • Tan, Aik Choon;
    • Haura, Eric;
    • Scott, Jacob;
    • Marusyk, Andriy
    Publication type:
    Article
    50